Professional Documents
Culture Documents
THE QUALIFICATIONS
Conducted Arctic expeditions for the U.S. Army, Navy, Air Force
and National Institutes of Health, studying poisonous and
venomous marine animals, and potential drugs from the sea.
THE RAID
"Mr. Dix then came in contact with ADS [the herbal compound]. After
taking ADS for about ten days, Mrs. Dix began to feel better, started
doing housework, shopping, traveling, and started entertaining again. I
met Mr. and Mrs. Dix one day in the lobby of a hotel in Pasadena. She
was walking, mentally alert, happy and laughing, and stated
emphatically that she was feeling great. No aches or pains - thanks to
ADS.
"At the time of the raid at the Dix home, the D.A. confiscated all of her
ADS. Her husband begged and tearfully pleaded with the D.A. to
release enough of the ADS for his wife's use. The D.A. refused to
release any of the tea to her.
"The next time I saw Mrs. Dix was in the courtroom. She looked pale, in
a weakened condition, unable to walk, crestfallen and anguished. A
few days later she died - a broken woman, a victim of the land of the
free and the home of the brave.
"What has happened to our national ideal of life, liberty and pursuit of
happiness? Why has the prosecution denied Mrs. Dix the right to retain
a cup of harmless adaptogenic tea which she purchased for her own
cancerous condition? What has happened to her civil liberties?
"I could not think of a single tyrannical country in which this scenario
could have taken place."
Perhaps, one might reason, Dr. Bruce Halstead's case and
claims are somewhat of an isolated example of government
intervention into the medical lives of Americans.
For those who question that power and money are the
controlling influences in the drug industry, Dr. Crout is also
quoted as saying, "I never have and never will approve a drug
to an individual, but only to a large pharmaceutical firm with
unlimited resources."
"It's the end of 14 years of war. It's the beginning of the end of the war
on cancer," he said.
"He predicted that the verdict would put his class of experimental
drugs, known as antineoplastons, on the fast track for approval by the
U.S. Food and Drug Administration.
"Burzynski now treats about 300 patients from all over the country,
most of whom have brain cancer and non-Hodgkin's lymphoma under
an FDA program for investigational new drugs."
Written 9/15/97